AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$26.58 USD
+0.24 (0.91%)
Updated May 3, 2024 04:00 PM ET
After-Market: $26.59 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
AnaptysBio, Inc. [ANAB]
Reports for Purchase
Showing records 81 - 100 ( 153 total )
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Partnered Dostarlimab Progress Positive, Awaiting ECLIPSE and ANB019 Updates
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 Financials; Quiet Days as Early Stage Pipeline Advances
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
D/g to NEUTRAL; Etokimab Miss Disappointing, but ANABs Still Better than Cash
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Revisiting Setup into Topline Ph 2b ATLAS Readout in Atopic Dermatitis
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
ANB019 First Patients Positive, Next Update in 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
2019 PacGrow Healthcare Conference: Day 1 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Our Thoughts Ahead of 4Q19 Data Flow; Reit Buy and $126 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A